Tracey Cleeland, is a
Case Manager/care Coordinator based in San Luis Obispo, California. Tracey Cleeland is licensed to practice in * (Not Available) (license number ) and her current practice location is
1255 Kendall Rd, San Luis Obispo, California. She can be reached at her office (for appointments etc.) via phone at
(805) 781-3535.
NPI number for Tracey Cleeland is 1063617926 and her current mailing address is 1588 Bradford Rd, Cambria, California. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1063617926.
Healthcare Provider's Profile
Full Name | Tracey Cleeland |
---|
Gender | Female |
---|
Speciality | Case Manager/care Coordinator |
---|
Location | 1255 Kendall Rd, San Luis Obispo, California |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1063617926
- Provider Enumeration Date: 06/19/2007
- Last Update Date: 04/04/2023
Medical Identifiers
Medical identifiers for Tracey Cleeland such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1063617926 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
101Y00000X | Counselor | (* (Not Available)) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tracey Cleeland is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Tracey Cleeland, 1588 Bradford Rd, Cambria, CA 93428-5906 Ph: (805) 801-9775 | Tracey Cleeland, 1255 Kendall Rd, San Luis Obispo, CA 93401-8750 Ph: (805) 781-3535 |
Reviews and Comments